Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 6 studies | 20% ± 3% | |
oligodendrocyte | 5 studies | 23% ± 6% | |
epithelial cell | 4 studies | 27% ± 3% | |
astrocyte | 4 studies | 23% ± 7% | |
retinal bipolar neuron | 3 studies | 20% ± 4% | |
GABAergic neuron | 3 studies | 30% ± 2% | |
glutamatergic neuron | 3 studies | 34% ± 4% | |
oligodendrocyte precursor cell | 3 studies | 25% ± 8% | |
basal cell | 3 studies | 23% ± 7% | |
neuron | 3 studies | 18% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1297.79 | 1445 / 1445 | 100% | 3.51 | 183 / 183 |
prostate | 100% | 1630.18 | 245 / 245 | 100% | 3.45 | 501 / 502 |
thymus | 100% | 2023.49 | 653 / 653 | 100% | 3.91 | 602 / 605 |
brain | 100% | 1223.66 | 2639 / 2642 | 99% | 3.73 | 700 / 705 |
lung | 100% | 1282.59 | 578 / 578 | 98% | 3.27 | 1137 / 1155 |
breast | 100% | 1451.70 | 459 / 459 | 98% | 3.51 | 1099 / 1118 |
uterus | 100% | 1738.49 | 170 / 170 | 98% | 3.19 | 451 / 459 |
skin | 100% | 1398.24 | 1809 / 1809 | 98% | 3.55 | 463 / 472 |
bladder | 100% | 1412.52 | 21 / 21 | 98% | 2.90 | 494 / 504 |
pancreas | 100% | 753.07 | 327 / 328 | 98% | 3.10 | 175 / 178 |
intestine | 100% | 1478.31 | 966 / 966 | 98% | 2.61 | 516 / 527 |
stomach | 100% | 1138.83 | 359 / 359 | 98% | 2.65 | 279 / 286 |
ovary | 100% | 1534.26 | 180 / 180 | 97% | 2.73 | 419 / 430 |
kidney | 100% | 1155.70 | 89 / 89 | 96% | 2.54 | 862 / 901 |
adrenal gland | 100% | 1298.52 | 258 / 258 | 94% | 2.62 | 216 / 230 |
liver | 100% | 1149.72 | 226 / 226 | 92% | 2.30 | 375 / 406 |
adipose | 100% | 1281.31 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1356.82 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 2.92 | 29 / 29 |
muscle | 100% | 1255.78 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1731.10 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 3.26 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.65 | 1 / 1 |
heart | 99% | 790.37 | 851 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 3.42 | 77 / 80 |
peripheral blood | 92% | 809.55 | 859 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006974 | Biological process | DNA damage response |
GO_0031048 | Biological process | regulatory ncRNA-mediated heterochromatin formation |
GO_1902369 | Biological process | negative regulation of RNA catabolic process |
GO_0046833 | Biological process | positive regulation of RNA export from nucleus |
GO_0008380 | Biological process | RNA splicing |
GO_0051301 | Biological process | cell division |
GO_0006397 | Biological process | mRNA processing |
GO_0000278 | Biological process | mitotic cell cycle |
GO_0048255 | Biological process | mRNA stabilization |
GO_0016607 | Cellular component | nuclear speck |
GO_0005730 | Cellular component | nucleolus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0003674 | Molecular function | molecular_function |
Gene name | NRDE2 |
Protein name | NRDE-2, necessary for RNA interference, domain containing Nuclear exosome regulator NRDE2 (Protein NRDE2 homolog) |
Synonyms | C14orf102 |
Description | FUNCTION: Protein of the nuclear speckles that regulates RNA degradation and export from the nucleus through its interaction with MTREX an essential factor directing various RNAs to exosomal degradation . Changes the conformation of MTREX, precluding its association with the nuclear exosome and interaction with proteins required for its function in RNA exosomal degradation . Negatively regulates, for instance, the degradation of mRNAs and lncRNAs by inhibiting their MTREX-mediated recruitment to nuclear exosome . By preventing the degradation of RNAs in the nucleus, it promotes their export to the cytoplasm . U5 snRNP-associated RNA splicing factor which is required for efficient splicing of CEP131 pre-mRNA and plays an important role in centrosome maturation, integrity and function during mitosis . Suppresses intron retention in a subset of pre-mRNAs containing short, GC-rich introns with relatively weak 5' and 3' splice sites . Plays a role in DNA damage response . . |
Accessions | ENST00000628832.1 ENST00000556189.5 ENST00000553409.5 Q9H7Z3 ENST00000354366.8 G3V338 H0YJT0 H0YJT6 ENST00000554464.1 |